Insulin resistance and skin diseases
- PMID:25977937
- PMCID: PMC4419263
- DOI: 10.1155/2015/479354
Insulin resistance and skin diseases
Abstract
In medical practice, almost every clinician may encounter patients with skin disease. However, it is not always easy for physicians of all specialties to face the daily task of determining the nature and clinical implication of dermatologic manifestations. Are they confined to the skin, representing a pure dermatologic event? Or are they also markers of internal conditions relating to the patient's overall health? In this review, we will discuss the principal cutaneous conditions which have been linked to metabolic alterations. Particularly, since insulin has an important role in homeostasis and physiology of the skin, we will focus on the relationships between insulin resistance (IR) and skin diseases, analyzing strongly IR-associated conditions such as acanthosis nigricans, acne, and psoriasis, without neglecting emerging and potential scenarios as the ones represented by hidradenitis suppurativa, androgenetic alopecia, and hirsutism.
Figures


Similar articles
- [Cutaneous manifestations of metabolic syndrome].Holzer G, Straßegger B, Volc-Platzer B.Holzer G, et al.Hautarzt. 2016 Dec;67(12):982-988. doi: 10.1007/s00105-016-3891-2.Hautarzt. 2016.PMID:27815622Review.German.
- Dermatologic manifestations of polycystic ovary syndrome.Lee AT, Zane LT.Lee AT, et al.Am J Clin Dermatol. 2007;8(4):201-19. doi: 10.2165/00128071-200708040-00003.Am J Clin Dermatol. 2007.PMID:17645376Review.
- Dermatologic manifestation of hyperandrogenism: a retrospective chart review.Clark CM, Rudolph J, Gerber DA, Glick S, Shalita AR, Lowenstein EJ.Clark CM, et al.Skinmed. 2014 Mar-Apr;12(2):84-8.Skinmed. 2014.PMID:24933845
- Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism.Ozdemir S, Ozdemir M, Görkemli H, Kiyici A, Bodur S.Ozdemir S, et al.Acta Obstet Gynecol Scand. 2010;89(2):199-204. doi: 10.3109/00016340903353284.Acta Obstet Gynecol Scand. 2010.PMID:19900078
- Obesity and the skin: skin physiology and skin manifestations of obesity.Yosipovitch G, DeVore A, Dawn A.Yosipovitch G, et al.J Am Acad Dermatol. 2007 Jun;56(6):901-16; quiz 917-20. doi: 10.1016/j.jaad.2006.12.004.J Am Acad Dermatol. 2007.PMID:17504714Review.
Cited by
- [Cutaneous manifestations of metabolic syndrome].Holzer G, Straßegger B, Volc-Platzer B.Holzer G, et al.Hautarzt. 2016 Dec;67(12):982-988. doi: 10.1007/s00105-016-3891-2.Hautarzt. 2016.PMID:27815622Review.German.
- Abnormal expression of SIRTs in psoriasis: Decreased expression of SIRT 1-5 and increased expression of SIRT 6 and 7.Fan X, Yan K, Meng Q, Sun R, Yang X, Yuan D, Li F, Deng H.Fan X, et al.Int J Mol Med. 2019 Jul;44(1):157-171. doi: 10.3892/ijmm.2019.4173. Epub 2019 Apr 24.Int J Mol Med. 2019.PMID:31017270Free PMC article.
- The Safety and Impact of a Model of Intermittent, Time-Restricted Circadian Fasting ("Ramadan Fasting") on Hidradenitis Suppurativa: Insights from a Multicenter, Observational, Cross-Over, Pilot, Exploratory Study.Damiani G, Mahroum N, Pigatto PDM, Pacifico A, Malagoli P, Tiodorovic D, Conic RR, Amital H, Bragazzi NL, Watad A, Adawi M.Damiani G, et al.Nutrients. 2019 Aug 1;11(8):1781. doi: 10.3390/nu11081781.Nutrients. 2019.PMID:31374976Free PMC article.
- The role of hormones in the pathogenesis of psoriasis vulgaris.Roman II, Constantin AM, Marina ME, Orasan RI.Roman II, et al.Clujul Med. 2016;89(1):11-8. doi: 10.15386/cjmed-505. Epub 2016 Jan 15.Clujul Med. 2016.PMID:27004020Free PMC article.Review.
- Acanthosis nigricans: To be or not to be afraid.Popa ML, Popa AC, Tanase C, Gheorghisan-Galateanu AA.Popa ML, et al.Oncol Lett. 2019 May;17(5):4133-4138. doi: 10.3892/ol.2018.9736. Epub 2018 Nov 19.Oncol Lett. 2019.PMID:30944606Free PMC article.Review.
References
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical